Search Results - Open Polar - "biosimilar"

Select result number 1
1

The impact of biosimilars ’ entry in the EU market

by Joan Rovira, Jaime Espín, Leticia García, Antonio Olry De Labry
Published 2011

Get access
Get access

Text
Select result number 2
2

Evaluating biosimilars uptake and policy in Canada ...

by McClean, Alison
Published 2023
“... molecule drugs, biologic biosimilars are one potential way in which payers can reduce drug spending...”

Get access
Get access

Text
Select result number 3
3

Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis

by Mansell, Kerry, Bhimji, Hishaam, Eurich, Dean, Mansell, Holly
Published in BMC Health Services Research (2019)
“...BACKGROUND: In 2014 and 2015, biosimilars for the drugs filgrastim, infliximab, and insulin...”

Get access
Get access
Get access

Text
Select result number 4
4

A Patients' Perspective Towards the Injection Devices for Humira® and Imraldi® in a Nationwide Switching Program

by Karlsdottir, Kristin, Gunnarsdottir, Anna I., Grondal, Gerdur, Love, Thorvardur J., Stefansdottir, Elinborg, Davidsdottir, Loa G., Thorleifsdottir, Ragna H., Gudbjornsson, Bjorn
Published in Frontiers in Medicine (2022)
“... to its biosimilar Imraldi® in March 2019. The study aimed to explore the patient's perspective...”

Get access
Get access

Text